Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nafamostat Mesylate Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103896809A details a safer synthesis route for nafamostat mesylate intermediates. This method eliminates toxic cyanides and simplifies industrial scale-up for reliable supply chains.